RT Journal Article
SR Electronic
T1 Machine Learning Applied to Clinical Laboratory Data Predicts Patient-Specific, Near-Term Relapse in Patients in Medication for Opioid Use Disorder Treatment
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.10.20163881
DO 10.1101/2020.08.10.20163881
A1 Paul Pyzowski
A1 Barbara Herbert
A1 Wasim Q Malik
YR 2020
UL http://medrxiv.org/content/early/2020/08/14/2020.08.10.20163881.abstract
AB We have developed a data-driven, algorithmic method for identifying patients in an out-patient buprenorphine program at high risk for relapse in the following seven days. This method uses data already available in clinical laboratory data, can be made available in a timely matter, and is easily understandable and actionable by clinicians. Use of this method could significantly reduce the rate of relapse in addiction treatment programs by targeting interventions at those patients most at risk for near term relapse.Competing Interest StatementPyzowski is an employee, director, and shareholder of Altimate Health Corporation; Malik is a director and shareholder of Altimate Health Corporation; no other relationships or activities that could appear to have influenced the submitted work.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Pearl IRB 29 East McCarty Street, Suite 100 Indianapolis, IN 46225All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData in not available for third party use.